Cosmederm Bioscience has hired Steve Massah as its new Chief Operating Officer. As COO, Massah will provide strategic and tactical leadership, and management of manufacturing, product development, quality and product shipment and logistics. His work will ensure compliance with all government regulations and industry guidelines for the company’s portfolio of topical therapeutic products in the OTC, cosmeceutical skincare and prescription markets.

Massah will also play a key leadership role in product design, formulation technical product development, manufacturing and distribution of a significant pipeline of developmental stage OTC, cosmeceutical and prescription products being developed for major indications in dermatology and pain. He will also lead the company’s evaluation of licensing opportunities to support the growth and expansion of the Cosmederm Bioscience product portfolio.